Veru (STU:FMW) YoY EPS Growth : 83.67% (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Veru YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Veru's YoY EPS Growth for the quarter that ended in Mar. 2024 was 83.67%.

Veru's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was €-0.06.

Veru YoY EPS Growth Historical Data

The historical data trend for Veru's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veru YoY EPS Growth Chart

Veru Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

YoY EPS Growth

Get a 7-Day Free Trial

54.11

-37.57

132.35

-1,477.92

2.83

Veru Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EPS Growth	Get a 7-Day Free Trial															-140.49	72.08	80.00	83.89	83.67

Veru YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Veru's YoY EPS Growth for the fiscal year that ended in Sep. 2023 is calculated as:

	YoY EPS Growth (A: Sep. 2023 )
=	(Earnings per Share (Diluted) (A: Sep. 2023 )	-	Earnings per Share (Diluted) (A: Sep. 2022 ))	/	\| Earnings per Share (Diluted) (A: Sep. 2022 ) \|
=	(-1.031	-	-1.061)	/	\| -1.061 \|
=	2.83 %

Veru's YoY EPS Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EPS Growth (Q: Mar. 2024 )
=	(Earnings per Share (Diluted) (Q: Mar. 2024 )	-	Earnings per Share (Diluted) (Q: Mar. 2023 ))	/	\| Earnings per Share (Diluted) (Q: Mar. 2023 )) \|
=	(-0.064	-	-0.392)	/	\| -0.392 \|
=	83.67 %

Veru YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Veru's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Veru (STU:FMW) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veru Inc (STU:FMW) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

VERU:USA FMW:Germany

Address

2916 North Miami Avenue, Suite 1000, Miami, FL, USA, 33127

Website

https://www.verupharma.com

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.

Veru (STU:FMW) Headlines

No Headlines